share_log
Moomoo 24/7 ·  04/17 17:06

Nektar Therapeutics:Received Letter From Nasdaq Notifying Co It Regained Compliance With Minimum Bid Price Requirement for Continued Listing on Nasdaq

Nektar Therapeutics:收到纳斯达克的来信,通知该公司已恢复遵守继续在纳斯达克上市的最低投标价要求

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发